NASDAQ · SEED

Origin Agritech Limited

$1.00 -$0.01 (-0.99%) 1D Market open

Key Metrics

$12.25M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield 1.2%
Free cash flow −$4.79M
Beta · 1Y 0.78
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 8
    From its Mar 27 high, the share price fell 34%.

    Peak close $1.45 on Mar 27; trough close $0.96 on Jun 8. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Mar 27
    The stock moved +16.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27
  • Mar 12
    The stock moved +12.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$12.25M
Enterprise value$11.49M
Shares outstanding12.1M
52-wk range$0.91 – $2.49
Avg volume · 20D176.2K
Net cash $758.00K
Book value / share$-0.27
ExchangeNASDAQ
About Origin Agritech Limited
IPO dateMar 29, 2004
Employees97

Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio0.44
Quick ratio0.35
Debt / equity-0.45
Debt / EBITDA
Net cash $758.00K
Working capital−$11.72M

Cash Flow · TTM

Operating CF −$3.22M
Capex −$1.58M
Free cash flow −$4.79M
Buybacks
Dividends paid $153.00K
Shareholder yield 1.2%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-09-30 · computed by TickerWolf from SEC filings